RFI Archives - EverGlade

RFI

MCDC RFI Host-Based Diagnostics

MCDC’s Host-Based Diagnostics for Acute Infections RFI

Leave a Comment / All Posts / By

MCDC Request for Information HOST-BASED DIAGNOSTICS Final A Shift Toward Host-Response Diagnostics The Medical CBRN Defense Consortium (MCDC), managed by Advanced Technology International (ATI), has released a Request for Information (RFI) titled Host-Based Diagnostics for Acute Infections. Issued in support of the Capability Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND), […]

MCDC’s Host-Based Diagnostics for Acute Infections RFI Read More »

BARDA RFI Neuromuscular Junction

BARDA’s RRPV RFI on NMJ Micro-Physiological Systems for BoNT Evaluation

Leave a Comment / BARDA, Life Sciences / By

RRPV_RFI_BoNT-NMJ RFI Final Post Overview of Solicitation The Rapid Response Partnership Vehicle (RRPV), on behalf of the Biomedical Advanced Research and Development Authority (BARDA), has released a Request for Information (RFI) focused on neuromuscular junction (NMJ) micro-physiological systems (MPS) for botulinum neurotoxin (BoNT) applications. Managed by Advanced Technology International (ATI), this RFI seeks to assess

BARDA’s RRPV RFI on NMJ Micro-Physiological Systems for BoNT Evaluation Read More »

DARPA Hemorrhage Countermeasures RFI

DARPA Hemorrhage Countermeasures RFI

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-SN-26-61 Overview of Solicitation Hemorrhage remains one of the leading causes of preventable death on the battlefield, with existing countermeasures often falling short in their transition from laboratory research to clinical and commercial application. In response, the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) has released a Request for Information (RFI) under

DARPA Hemorrhage Countermeasures RFI Read More »

BARDA RFI ARDS Prevention

BARDA RFI on Host-Directed Therapeutics for ARDS Prevention

Leave a Comment / BARDA, Life Sciences / By

Overview of Solicitation The Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services, has released a Request for Information (RFI)/Sources Sought Notice (SSN) titled “Host Directed Therapeutics for the Prevention of Progression to ARDS.” This effort, in support of BARDA’s

BARDA RFI on Host-Directed Therapeutics for ARDS Prevention Read More »

MCDC Host-Directed Therapeutics Initiative

MCDC’s Host-Directed Therapeutics Initiative

Leave a Comment / All Posts / By

The Medical Chemical, Biological, Radiological, and Nuclear Defense Consortium (MCDC), managed by Advanced Technology International (ATI), has issued a Request for Information (RFI) focused on “Host-Directed Medical Countermeasures.” This effort, led in support of the Capability Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND), represents an early step toward shaping a

MCDC’s Host-Directed Therapeutics Initiative Read More »

MCDC Prophylaxis Military Protection

MCDC Seeks Industry Input on Prophylaxis in Advanced Development for Military Biological Threat Protection

Leave a Comment / All Posts / By

The Medical CBRN Defense Consortium (MCDC), through Advanced Technology International (ATI), has issued a Request for Information (RFI) on behalf of the Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) for “Prophylaxis in Advanced Development.” This notice is intended strictly for information gathering and planning and does not constitute a Request

MCDC Seeks Industry Input on Prophylaxis in Advanced Development for Military Biological Threat Protection Read More »

BARDA next generation vaccine platforms

BARDA Seeks Next-Generation Vaccine Platforms to Accelerate National Preparedness

Leave a Comment / BARDA, Life Sciences / By

New-Vaccine-Platforms-RFI_Amd-1.pdf The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), has released a new Request for Information (RFI) focused on “New Vaccine Platforms.” This solicitation seeks to better understand the current landscape of vaccine platform technologies

BARDA Seeks Next-Generation Vaccine Platforms to Accelerate National Preparedness Read More »

JPEO RFI for Faster CBRN Medical Countermeasures

JPEO-CBRND’s New Approach Methods RFI for Faster CBRN Medical Countermeasures

Leave a Comment / JPEO, Life Sciences / By

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense – Enabling Biotechnologies (JPEO-CBRND-EB) has released a Request for Information (RFI) on New Approach Methods (NAMs) to support medical countermeasure (MCM) development against chemical, biological, radiological, and nuclear (CBRN) threats. In line with broader efforts at the Food and Drug Administration (FDA) and

JPEO-CBRND’s New Approach Methods RFI for Faster CBRN Medical Countermeasures Read More »

JPEO RFI Wearable Sensors

JPEO-CBRND RFI: Wearable Sensors for Real-Time CBRN Threat Monitoring

Leave a Comment / JPEO, Life Sciences / By

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has released a new Request for Information (RFI) focused on advancing wearable Chem-Bio-Radiological-Nuclear (CBRN) monitoring technologies. As the Department of Defense (DoD) continues strengthening preparedness for complex, multi-domain threats, this RFI seeks industry input on next-generation wearable sensors capable of supporting warfighter

JPEO-CBRND RFI: Wearable Sensors for Real-Time CBRN Threat Monitoring Read More »

BARDA pandemic influenza vaccine partnerships

BARDA Seeks Industry Input for Pandemic Influenza Vaccine Partnerships

Leave a Comment / BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), has released a new Sources Sought Notice (SSN) and Request for Information (RFI) focused on vaccine medical countermeasures (MCMs) for pandemic influenza preparedness and response. This initiative underscores BARDA’s ongoing commitment to strengthening the nation’s biosecurity

BARDA Seeks Industry Input for Pandemic Influenza Vaccine Partnerships Read More »

BARDA RAPID RFI antibodies

BARDA’s RAPID RFI for Next-Generation Antibody Design through Production

Leave a Comment / BARDA, Life Sciences / By

BARDA RAPID RFI RAPID Overview The Biomedical Advanced Research and Development Authority (BARDA) has issued a new Request for Information (RFI) titled “Rapid Antibody Production for Immunoassay Diagnostics (RAPID)”. Through this RFI, BARDA seeks to more deeply understand causes of existing bottlenecks in the antibody generation process (design through production) and assess the R&D landscape

BARDA’s RAPID RFI for Next-Generation Antibody Design through Production Read More »

JPEO RFI genetic sequencing

JPEO-CBRND Seeks Next-Generation Genomic Sequencing Capabilities for the Battlefield

Leave a Comment / JPEO, Life Sciences / By

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has released a new Request for Information (RFI) titled “End-to-End Untargeted Genomic Sequencing Workflows Appropriate for Military Use.” This RFI underscores the Department of Defense’s (DoD) growing emphasis on rapid, field-deployable biological threat detection, a critical component of maintaining operational readiness in

JPEO-CBRND Seeks Next-Generation Genomic Sequencing Capabilities for the Battlefield Read More »

Scroll to Top